<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Pregnancy Childbirth</journal-id><journal-id journal-id-type="iso-abbrev">BMC Pregnancy Childbirth</journal-id><journal-id journal-id-type="publisher-id">BMC Pregnancy Childbirth</journal-id><journal-title-group><journal-title>BMC Pregnancy and Childbirth</journal-title></journal-title-group><issn pub-type="epub">1471-2393</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3877981</article-id><article-id pub-id-type="publisher-id">1471-2393-13-232</article-id><article-id pub-id-type="doi">10.1186/1471-2393-13-232</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Induction of labour versus expectant monitoring for
gestational hypertension or mild pre-eclampsia between 34 and
37&#x000a0;weeks&#x02019; gestation (HYPITAT-II): a multicentre, open-label
randomised controlled trial</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author" corresp="yes"><name><surname>Broekhuijsen</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>k.broekhuijsen@gmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Langenveld</surname><given-names>Josje</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>josje_langenveld@hotmail.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>van Baaren</surname><given-names>Gert-Jan</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>g.j.vanbaaren@amc.uva.nl</email></contrib><contrib id="A4" contrib-type="author"><name><surname>van Pampus</surname><given-names>Mari&#x000eb;lle G</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>m.g.vanpampus@olvg.nl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>van Kaam</surname><given-names>Anton H</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>a.h.vankaam@amc.uva.nl</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Groen</surname><given-names>Henk</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>h.groen01@umcg.nl</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Porath</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>m.porath@mmc.nl</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Franssen</surname><given-names>Maureen TM</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>m.t.m.franssen@umcg.nl</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Mol</surname><given-names>Ben W</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>b.w.mol@amc.uva.nl</email></contrib><on-behalf-of>HYPITAT-II study group<xref ref-type="corresp" rid="d33e94"/></on-behalf-of></contrib-group><aff id="I1"><label>1</label>Department of Obstetrics and Gynecology, University of
Groningen, University Medical Center Groningen, Groningen, The Netherlands</aff><aff id="I2"><label>2</label>Department of Obstetrics and Gynecology, Atrium Medical
Center, Heerlen, The Netherlands</aff><aff id="I3"><label>3</label>Department of Obstetrics and Gynecology, Academic Medical
Center, Amsterdam, The Netherlands</aff><aff id="I4"><label>4</label>Department Obstetrics and Gynecology, Onze Lieve Vrouwe
Gasthuis, Amsterdam, The Netherlands</aff><aff id="I5"><label>5</label>Department of Epidemiology, University of Groningen,
University Medical Center Groningen, Groningen, The Netherlands</aff><aff id="I6"><label>6</label>Department of Obstetrics and Gynecology, Maxima Medical
Center, Veldhoven, The Netherlands</aff><author-notes><corresp id="d33e94">HYPITAT-II study group</corresp></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2013</year></pub-date><volume>13</volume><fpage>232</fpage><lpage>232</lpage><history><date date-type="received"><day>24</day><month>1</month><year>2013</year></date><date date-type="accepted"><day>6</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Broekhuijsen et al.; licensee BioMed
Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Broekhuijsen et al.; licensee BioMed Central
Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an open access article distributed under the terms of the
Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2393/13/232"/><related-article id="d35e201" related-article-type="corrected-article" xlink:href="21736705" ext-link-type="pubmed" vol="11" page="50"/></article-meta></front><body><p>The earliest draft versions of the protocol for our study described the composite
adverse maternal outcome as one or more of progression to severe disease, pulmonary
edema, thrombo-embolic disease, HELLP syndrome, eclampsia, placental abruption or
maternal death. However, there is ongoing debate as to whether progression to severe
disease should be considered an adverse maternal outcome [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Therefore, after
obtaining funding which enabled us to increase our sample size to the current sample
size of 680, we decided to study a composite adverse maternal outcome excluding
progression to severe disease. These changes were incorporated in the protocol as
submitted to and approved by the instutional review board;* the current protocol is
available from our website (<ext-link ext-link-type="uri" xlink:href="http://www.studies-obsgyn.nl/hypitat2/page.asp?page_id=642">http://www.studies-obsgyn.nl/hypitat2/page.asp?page_id=642</ext-link>).
Unfortunately, the change to the maternal outcome definition was not incorporated
into the published protocol, which incorrectly includes progression to severe
disease in the composite adverse maternal outcome [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>We also discovered minor differences between the published protocol and the IRB
approved protocol. The definition for neonatal morbidity should have contained
meconium aspiration syndrome, pneumothorax and/or pneumomediastinum, periventricular
leucomalacia, convulsions and other neurological abnormalities. Finally, low
5-minute Apgar score should have been defined as below 7 (as opposed to below 3),
and low umbilical artery pH as below 7.05 (as opposed to below 7.0).</p><p>These discrepancies were discovered and the correction submitted for publication
during recruitment.</p><p>* Medical Ethics Committee, Academic Medical Centre, Amsterdam, the Netherlands (ref.
2008/244).</p><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p>
<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2393/13/232/prepub">http://www.biomedcentral.com/1471-2393/13/232/prepub</ext-link>
</p></sec></body><back><ref-list><ref id="B1"><element-citation publication-type="journal"><name><surname>Koopmans</surname><given-names>CM</given-names></name><name><surname>Bijlenga</surname><given-names>D</given-names></name><name><surname>Groen</surname><given-names>H</given-names></name><name><surname>Vijgen</surname><given-names>SM</given-names></name><name><surname>Aarnoudse</surname><given-names>JG</given-names></name><name><surname>Bekedam</surname><given-names>DJ</given-names></name><collab>HYPITAT study group</collab><etal/><article-title>Induction of labour versus expectant monitoring for gestational
hypertension or mild pre-eclampsia after 36 weeks&#x02019; gestation
(HYPITAT): a multicentre, open-label randomised controlled
trial</article-title><source>Lancet</source><year>2009</year><volume>13</volume><fpage>979</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(09)60736-4</pub-id><pub-id pub-id-type="pmid">19656558</pub-id></element-citation></ref><ref id="B2"><element-citation publication-type="journal"><name><surname>Bewley</surname><given-names>S</given-names></name><name><surname>Shennan</surname><given-names>A</given-names></name><article-title>Hypitat and the fallacy of pregnancy interruption</article-title><source>Lancet</source><year>2010</year><volume>13</volume><issue>9709</issue><fpage>119</fpage><pub-id pub-id-type="pmid">20109885</pub-id></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><name><surname>Langenveld</surname><given-names>J</given-names></name><name><surname>Broekhuijsen</surname><given-names>K</given-names></name><name><surname>van Baaren</surname><given-names>G</given-names></name><name><surname>van Pampus</surname><given-names>MG</given-names></name><name><surname>van Kaam</surname><given-names>AH</given-names></name><name><surname>Groen</surname><given-names>H</given-names></name><name><surname>Porath</surname><given-names>M</given-names></name><name><surname>Mol</surname><given-names>BW</given-names></name><collab>HYPITAT-II study group</collab><article-title>Induction of labour versus expectant monitoring for gestational
hypertension or mild pre-eclampsia between 34 and 37 weeks&#x02019;
gestation (HYPITAT-II): a multicentre, open-label randomised controlled
trial</article-title><source>BMC Pregnancy Childbirth</source><year>2011</year><volume>13</volume><fpage>50</fpage><pub-id pub-id-type="doi">10.1186/1471-2393-11-50</pub-id><pub-id pub-id-type="pmid">21736705</pub-id></element-citation></ref></ref-list></back></article>